Eur J Pediatr Surg 2016; 26(01): 128-132
DOI: 10.1055/s-0035-1568995
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Mesohepatectomy for Centrally Located Tumors in Children

Authors

  • Maria Virginia Amesty

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • Gloria Chocarro

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • Alejandra Vilanova Sánchez

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • Vanesa Nuñez Cerezo

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • C. A. de la Torre

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • Jose Luis Encinas

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • Manuel Gamez Arance

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • Francisco Hernández

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
  • Manuel Lopez Santamaria

    1   Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Madrid, Spain
Further Information

Publication History

25 May 2015

14 October 2015

Publication Date:
04 December 2015 (online)

Preview

Abstract

Introduction Central hepatectomy or mesohepatectomy (MH) is a complex surgical technique rarely used in children. It is indicated in central tumors to preserve functioning liver mass avoiding an extended right hepatectomy. The purpose of this article is to analyze our experience with this technique.

Methods We reviewed five patients who underwent MH in the period from 2008 to 2014. Diagnoses were hepatoblastoma PRETEXT III (two cases), hepatic embryonal sarcoma (one case), focal nodular hyperplasia (one case), and vascular tumor with rapid growth in a newborn causing an acute liver failure, compartment syndrome, and multiple organ failure (one case). In all cases, the tumor was centrally located, including the segment IVb, with large displacement of the hepatic pedicle in two cases.

Results MH was standard in three cases and under total vascular exclusion in two cases. All children are alive with a mean follow-up of 38 (6–70) months. None of the children required reoperation because of bleeding. One child developed a biliary fistula in the cutting area that closed spontaneously. The newborn with the vascular tumor required the placement of a Gore-Tex patch (W. L. Gore & Associates, Inc, Flagstaff, Arizona, United States) to relieve the compartment syndrome. He subsequently underwent partial embolization of the tumor and MH under vascular exclusion.

Conclusions In selected patients, MH is an alternative to trisegmentectomy and should be available in advanced pediatric hepatobiliary units.